Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
01/03/2003 | CA2450921A1 Protein modification and maintenance molecules |
01/03/2003 | CA2449990A1 Type 1 diabetes diagnostics and therapeutics |
01/03/2003 | CA2448222A1 Culture apparatus and cultivation method |
01/02/2003 | US20030005489 Regeneration system for grape and uses thereof |
01/02/2003 | US20030005480 Stress resistant plant in which cell death suppressing gene is introduced and method for producing the same |
01/02/2003 | US20030005478 Methods |
01/02/2003 | US20030005470 Animal model for use in the diagnosis and treatment of tumors and bone matastasis |
01/02/2003 | US20030004327 Cerebellum and embryo specific protein |
01/02/2003 | US20030004324 31 human secreted proteins |
01/02/2003 | US20030004317 Nucleic acids encoding anti-human alphanubeta3 and alphanubeta5 antibodies |
01/02/2003 | US20030004310 Culture product |
01/02/2003 | US20030004306 Fluorescent protein |
01/02/2003 | US20030004133 Wound healing agents, antiulcer agents |
01/02/2003 | US20030004106 Interleukin-1 receptor antagonist-related molecules and uses thereof |
01/02/2003 | US20030004102 Genetic engineering; immunosuppressants, anticancer agents |
01/02/2003 | US20030004095 Treatment of diabetes with milk protein hydrolysate |
01/02/2003 | US20030004065 Electrically generated silver ions to control plant disease; bactericides; fungicides, viricides; algicides; irrigation; water treatment; electrical anodic corrosion of a silver wire in aqueous medium |
01/02/2003 | US20030003581 Method for targeting transcriptionally active loci |
01/02/2003 | US20030003579 Dendritic cells; methods |
01/02/2003 | US20030003576 Peripheral blood fibrocytes differentiation pathway and migration to wound sites |
01/02/2003 | US20030003575 Apparatus for use in the generation of thin layered films |
01/02/2003 | US20030003574 Multipotent stem cells from peripheral tissues and uses thereof |
01/02/2003 | US20030003573 Cells for use in the treatment of liver disorders |
01/02/2003 | US20030003572 Propagation of preefrential nercous system tissue; obtain cells, inoculate nutrient broth containing nerve growth factor, propagate and recover cells |
01/02/2003 | US20030003567 Packaging cells |
01/02/2003 | US20030003566 Cell line preparing and producing ovine adenovirus vectors |
01/02/2003 | US20030003555 Nucleotide sequences coding proteins for use in the diagnosis and treatment of hematopoietic or immune disorders |
01/02/2003 | US20030003554 Generation of preferential solid support; obtain chemical intermediates, incubate with reaction mixture, immerse in thin film, dry, recover support |
01/02/2003 | US20030003546 Treating degenerative cartilaginous disorders and other inflammatory diseases |
01/02/2003 | US20030003545 Nucleotide sequences coding polypeptide for use in the treatment of immunological defects |
01/02/2003 | US20030003543 Methods and applications for efficient genetic suppressor elements |
01/02/2003 | US20030003542 ACPL polypeptides |
01/02/2003 | US20030003541 Nucleotide sequences coding peptide for use in the treatment of skin, brain and eye disorders |
01/02/2003 | US20030003538 Neuropathic pain genes; compositions thereof; related reagents |
01/02/2003 | US20030003536 Vanilloid receptor |
01/02/2003 | US20030003535 Single chain class I major histo-compatibility complexes |
01/02/2003 | US20030003532 Novel nucleic acid sequences encoding human slit-, megf-, and roundabout-like polypeptides |
01/02/2003 | US20030003531 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
01/02/2003 | US20030003530 Nucleotide sequences coding protein for use in diagnosis and treatment of skin and cancer disorders |
01/02/2003 | US20030003508 Serological diagnostic method with rickettsia pulicis bacterium |
01/02/2003 | US20030003478 Identifying and characterizing genes |
01/02/2003 | US20030003477 Nucleotide sequences coding polypeptides for use in the treatment of nervous system, kidney, muscle, allergic and cancer disorders |
01/02/2003 | US20030003472 Detection of genetic aberration in sample; obtain nucleotide sequences, incubate with oligonucleotides, detect aberration in hybridization, presence of aberration indicates variablity in nucleotide sequences |
01/02/2003 | US20030003466 Artificial mammalian chromosome |
01/02/2003 | US20030003462 Novel human interleukin-like proteins and polynucleotides encoding them |
01/02/2003 | US20030003452 Polymerase for use in the treatment of infections, respiratory, blood, alzheimer's, muscular and cancerous disorders |
01/02/2003 | US20030003448 Method |
01/02/2003 | US20030003447 Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus |
01/02/2003 | US20030003443 Designation MVP-5180/91, deposited with the European Collection of Animal Cell Cultures under No V 920 92 318 |
01/02/2003 | US20030003442 Retrovirus from the HIV group and its use |
01/02/2003 | US20030003164 Use of dictyotal extracts in the production of a topical composition |
01/02/2003 | US20030003098 Treating graft with molecule which binds to co-stimulatory protein of antigen-presenting cells |
01/02/2003 | US20030003097 Recombinant antibodies coexpressed with GnTIII |
01/02/2003 | US20030003090 Increasing the intracellular level of cyclic AMP; treating a human patient having a disease, condition, or disorder of the central nervous system |
01/02/2003 | US20030003089 Cells organized on a support to provide a three-dimensional cell structure; used for research or drug testing, in surgical implantation for the treatment of heart disease |
01/02/2003 | US20030003088 A human pancreatic ductal cell line immortalized with human papilloma virus genes E6 and E7 and which is capable of produce insulin; treating insulin-dependent diabetes; determining a chemical agent to induce cell differentiation |
01/02/2003 | US20030003087 Use of marrow-derived glial progenitor cells as gene delivery vehicles into the central nervous system |
01/02/2003 | US20030003086 A genetic engineered cell comprising an exogenously derived nucleic acid coding for a thimet oligopeptidase (TOP) polypeptide; modulate antigen presentation on cell surfaces, works synergistically with immunosuppressive drugs |
01/02/2003 | US20030003085 Drug delivery of a muscle protein by administering purified donor muscle side population cells; gene therapy, in the treatment muscle diseases muscular dystrophies, genetic diseases, treating cancer, and bone marrow transplant |
01/02/2003 | US20030003084 Human mesenchymal progenitor cell |
01/02/2003 | US20030003083 Administering a dose of non- alloreactive anti-third party cytotoxic T-lymphocytes (CTLs), which were generated by directing T-lymphocytes of the donor against a third party antigen or antigens |
01/02/2003 | EP1271153A2 Collapsin response mediator protein-1 as tumor metastasis marker |
01/02/2003 | EP1270744A1 Reporter gene construct for the detection of HIV rev and HIV tat |
01/02/2003 | EP1270741A1 Nucleotide sequences involved in plant disease resistance |
01/02/2003 | EP1270732A1 Improved transfection of eukaryontic cells with linear polynucleotides by electroporation |
01/02/2003 | EP1270727A1 Salutaridinol 7-O-acetyltransferase and derivatives thereof |
01/02/2003 | EP1270720A2 Activated rec-D-Hydantoinases |
01/02/2003 | EP1270719A2 Cell population containing non-fetal hemangioblasts and method for producing same |
01/02/2003 | EP1270718A1 Cell culturing method and device |
01/02/2003 | EP1270593A2 HSCA-3 antigen and monoclonal antibody which recognizes the antigen |
01/02/2003 | EP1270591A1 Transgenic cells and a method for detecting disruptors for androgens by using said transgenic cells |
01/02/2003 | EP1270590A1 Human CD24-like protein and nucleic acids encoding it |
01/02/2003 | EP1270588A1 Novel collagen-like protein clac, precursor thereof and genes encoding the same |
01/02/2003 | EP1270533A2 Ceramic materials, method for their production and use thereof |
01/02/2003 | EP1268836A2 Novel sperm-dna complexes for genetically modifying non-human animals |
01/02/2003 | EP1268835A1 Retinoic acid receptor beta-2, its antagonists, and gene therapy vectors for the treatment of neurological disorders |
01/02/2003 | EP1268820A2 Estrogen-regulated myo-inositol phosphate synthase: compositions and methods of use |
01/02/2003 | EP1268819A2 Muskmelon (cucumis melo) hydroperoxide lyase and uses thereof |
01/02/2003 | EP1268817A1 Human pyruvate dehydrogenese phosphatase |
01/02/2003 | EP1268816A2 Calcium-binding regulatory subunit |
01/02/2003 | EP1268813A2 Thermophilic polymerase iii holoenzyme |
01/02/2003 | EP1268812A2 Vectors for gene therapy |
01/02/2003 | EP1268802A2 Beta-like glycoprotein hormone polypeptide and heterodimer |
01/02/2003 | EP1268799A2 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability |
01/02/2003 | EP1268798A2 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains |
01/02/2003 | EP1268797A2 Compositions and methods for the therapy and diagnosis of lung cancer |
01/02/2003 | EP1268796A1 Identification of human gaba transporter |
01/02/2003 | EP1268793A2 Fibroblast growth factor receptor-like molecules and uses thereof |
01/02/2003 | EP1268792A2 Wnt-7b-like polypeptides and nucleic acids encoding same |
01/02/2003 | EP1268790A1 Gene coding for erbin, and diagnostic and therapeutic uses thereof |
01/02/2003 | EP1268787A2 Human tap-like protein (transporter associated in antigen processing/presentation) |
01/02/2003 | EP1268785A2 Gtp-binding protein gamma-12 subunit |
01/02/2003 | EP1268784A2 Genes involved in intestinal inflammatory diseases and use thereof |
01/02/2003 | EP1268783A2 Anti-angiogenic and anti-tumor properties of matin and other laminin domains |
01/02/2003 | EP1268782A2 Apolipoprotein-a-i regulation of t-cell signalling |
01/02/2003 | EP1268781A2 G12l, a gene associated with the thermal response |
01/02/2003 | EP1268778A1 Materials and methods relating to a novel splice variant of a na + dependent glutamate transporter |
01/02/2003 | EP1268775A1 The high bone mass gene of 11q13.3 |
01/02/2003 | EP1268773A1 Immune system-related polynucleotides, polypeptides, and antibodies |
01/02/2003 | EP1268772A2 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system |